Why is Shilpa Medicare falling/rising?

As of 26-Sep, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 770.00, which reflects a decrease of Rs 23.7 or 2.99%. The stock has underperformed its sector by 0.65% today and has been on a downward trend for the last three days, accumulating a total loss of 6.73% during this period. Additionally, the stock has touched an intraday low of Rs 757, indicating significant selling pressure. Despite the company reporting a remarkable growth in net profit of 290.01% and positive results for the last eight consecutive quarters, the stock's performance has been lackluster, with a year-to-date return of -5.29% compared to the Sensex's gain of 2.93%. The stock is also trading below all its moving averages, suggesting a bearish sentiment among investors.
In the broader market context, Shilpa Medicare's recent performance contrasts with the Sensex, which has only declined by 2.66% over the past week. While the pharmaceutical sector has faced a downturn of 2.34%, the stock's continued decline may be attributed to its weak long-term fundamental strength, with an average return on capital employed (ROCE) of 4.61% and slow growth in net sales and operating profit over the last five years. Although the stock is trading at a discount compared to its peers and has a favorable PEG ratio of 0.2, the overall market sentiment and recent performance suggest that investors are cautious, leading to the stock's current downward trajectory.